These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30506606)

  • 1. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis using 4-Fr pancreatic plastic stents placed with common-type guidewires: Results from a prospective multinational registry.
    Sahar N; Ross A; Lakhtakia S; Coté GA; Neuhaus H; Bruno MJ; Haluszka O; Kozarek R; Ramchandani M; Beyna T; Poley JW; Maranki J; Freeman M; Kedia P; Tarnasky P;
    Dig Endosc; 2019 May; 31(3):299-306. PubMed ID: 30506606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic stent prophylaxis of post endoscopic retrograde cholangiopancreatography pancreatitis: spontaneous migration rates and clinical outcomes.
    Chahal P; Baron TH; Petersen BT; Topazian MD; Gostout CJ; Levy MJ
    Minerva Gastroenterol Dietol; 2007 Sep; 53(3):225-30. PubMed ID: 17912184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic stents in the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography].
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Orv Hetil; 2021 Jan; 162(1):31-38. PubMed ID: 33388737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.
    Pahk A; Rigaux J; Poreddy V; Smith J; Al-Kawas F
    Dig Dis Sci; 2011 Oct; 56(10):3058-64. PubMed ID: 21487771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of post-ERCP pancreatitis in high-risk patients despite prevention with prophylactic pancreatic stents.
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Scand J Gastroenterol; 2020 Jan; 55(1):95-99. PubMed ID: 31852319
    [No Abstract]   [Full Text] [Related]  

  • 6. Moderate and severe postendoscopic retrograde cholangiopancreatography pancreatitis despite prophylactic pancreatic stent placement: the effect of early prophylactic pancreatic stent dislodgement.
    Moffatt DC; Pradermchai K; Avula H; Sherman S; Fogel EL; Lehman GA
    Can J Gastroenterol; 2011 Apr; 25(4):215-9. PubMed ID: 21523263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial.
    Conigliaro R; Manta R; Bertani H; Manno M; Barbera C; Caruso A; Olivetti G; Melotti G; Frazzoni M
    Surg Endosc; 2013 Feb; 27(2):569-74. PubMed ID: 22926890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial.
    Zolotarevsky E; Fehmi SM; Anderson MA; Schoenfeld PS; Elmunzer BJ; Kwon RS; Piraka CR; Wamsteker EJ; Scheiman JM; Korsnes SJ; Normolle DP; Kim HM; Elta GH
    Endoscopy; 2011 Apr; 43(4):325-30. PubMed ID: 21455872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study.
    Cha SW; Leung WD; Lehman GA; Watkins JL; McHenry L; Fogel EL; Sherman S
    Gastrointest Endosc; 2013 Feb; 77(2):209-16. PubMed ID: 23084272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis.
    Afghani E; Akshintala VS; Khashab MA; Law JK; Hutfless SM; Kim KJ; Lennon AM; Kalloo AN; Singh VK
    Endoscopy; 2014 Jul; 46(7):573-80. PubMed ID: 24830399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any difference in outcomes between long pigtail and short flanged prophylactic pancreatic duct stents?
    Iqbal S; Shah S; Dhar V; Stavropoulos SN; Stevens PD
    Dig Dis Sci; 2011 Jan; 56(1):260-5. PubMed ID: 20464492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transabdominal ultrasonography to reduce the burden of X-ray imaging in prophylactic pancreatic stent localization after ERCP-A prospective trial.
    Michael FA; Gerber L; Weiler N; Hunyady PM; Abedin N; de la Vera AL; Stoffers P; Filmann N; Zeuzem S; Bojunga J; Friedrich-Rust M; Dultz G
    United European Gastroenterol J; 2021 May; 9(4):469-477. PubMed ID: 33887119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
    World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial.
    Ito K; Fujita N; Noda Y; Kobayashi G; Obana T; Horaguchi J; Takasawa O; Koshita S; Kanno Y; Ogawa T
    J Gastroenterol; 2010 Nov; 45(11):1183-91. PubMed ID: 20607310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early pancreatic stent placement in wire-guided biliary cannulation: A multicenter retrospective study.
    Hakuta R; Hamada T; Nakai Y; Isayama H; Kogure H; Takahara N; Mizuno S; Yagioka H; Togawa O; Matsubara S; Ito Y; Yamamoto N; Tada M; Koike K
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1116-1122. PubMed ID: 30152138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Efficacy of 3- or 5-cm Pancreatic Stents for Preventing Post-ERCP Pancreatitis: A Prospective, Randomized Trial.
    Fujisawa T; Kagawa K; Ochiai K; Hisatomi K; Kubota K; Sato H; Nakajima A; Matsuhashi N
    J Clin Gastroenterol; 2016 Mar; 50(3):e30-4. PubMed ID: 26280707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feasibility of pancreatic duct stenting using a novel 4-Fr plastic stent with a 0.025-in. guidewire.
    Nagai K; Sofuni A; Tsuchiya T; Ishii K; Tanaka R; Tonozuka R; Mukai S; Yamamoto K; Matsunami Y; Asai Y; Kurosawa T; Kojima H; Minami H; Honma T; Katanuma A; Itoi T
    Sci Rep; 2021 Jul; 11(1):14285. PubMed ID: 34253746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.